TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioInvent International AB
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 29,306 | 1,895 | 14,682 |
Financial expenses | 71 | 70 | 148 |
Earnings before taxes | -3,819 | -27,227 | -7,605 |
EBITDA | -4,576 | -27,217 | -7,519 |
Total assets | 153,861 | 141,520 | 79,964 |
Current assets | 97,415 | 109,126 | 77,016 |
Current liabilities | 7,847 | 5,749 | 5,331 |
Equity capital | 144,328 | 133,666 | 74,072 |
- share capital | 1,168 | 1,143 | 7,846 |
Employees (average) | 89 | 79 | 72 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 93.8% | 94.5% | 92.6% |
Turnover per employee | 329 | 24 | 204 |
Profit as a percentage of turnover | -13.0% | -1436.8% | -51.8% |
Return on assets (ROA) | -2.4% | -19.2% | -9.3% |
Current ratio | 1241.4% | 1898.2% | 1444.7% |
Return on equity (ROE) | -2.6% | -20.4% | -10.3% |
Change turnover | 27,564 | -12,515 | 5,343 |
Change turnover % | 1582% | -87% | 57% |
Chg. No. of employees | 10 | 7 | 4 |
Chg. No. of employees % | 13% | 10% | 6% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.